News

business partnership handshake merger acquisition M&A

Abbott acquires cancer diagnostic company Exact Sciences for $21B

The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.

Washington hospital open since 1887 pauses heart transplant program due to vacancies

No other heart or transplant services at the nonprofit hospital should be impacted by this temporary shift in care.

Boston Scientific partners with Epic on data integration

The collaboration allows providers to order diagnostic tests and then receive results directly in Epic.

Semaglutide, other obesity drugs show potential to treat nondiabetic stroke

Much more research is still required, but a new meta-analysis in Stroke suggests these medications may provide valuable stroke prevention.

Caon Medical USA ultrasound director Dan Skyba explains advances in ultrasound processing algorithms at RSNA 2025.

Canon gains FDA clearance for new ultrasound processing algorithms ahead of RSNA

The U.S. Food and Drug Administration has green-lit new updates that improve microvascular flow, AI-assisted harmonic imaging and elastography, which Canon will showcase at RSNA 2025.

‘Strongest growth in over a decade’: Heart tech helps Medtronic beat earnings expectations

The company's PFA and TAVR technologies both played key roles in the successful second quarter. In addition, Medtronic expects its place in the renal denervation market to make a major impact going forward.

Healthcare AI today: Noblesse oblige, European lag, inspirational leadership, more

One of the AI haves feels the pain of the AI have-nots. His discomfort is especially pronounced when he thinks about how hard it must be for financial strugglers to keep up with regulations and rumors of regulations to come.

Pennsylvania passes bill requiring coverage for supplemental breast imaging

It's slated to become the 31st state to finalize legislation eliminating out-of-pocket costs for follow-up exams after an abnormal screening mammogram.

Cigna announces new copay-centric insurance model, backed by AI care coordination

Dubbed “Clearity,” the new health plans will have four tiers to choose from, allowing patients to select the provider and services that are right for them. The insurance is similar to a concierge care model, but backed by a potentially larger network.

SCAI: Noncompete contracts unfairly bind cardiologists to hospitals unless they move

"These provisions are contained in what amounts, in many cases, to contracts of adhesion, because a physician’s only choice is to accept the terms of the contract without revision or else forgo employment," the Society for Cardiovascular Angiography and Interventions wrote to the U.S. Federal Trade Commission.

The new cardiac PET radiotracer flurpiridaz F-18 is posed to be a major game changer and will likely lead to increased adoption of cardiac PET.

Largest network of private cardiology groups in US to deploy GE HealthCare's cardiac PET tracer

One of the tracer’s more significant advantages is its extended half-life of 109 minutes—significantly longer than other currently available PET MPI imaging agents.

Generic CT and MRI Contrast Agents - Visit Fresenius Kabi at booth #3247

As the leading provider of generic contrast agents, Fresenius Kabi’s commitment is to provide you with choice and value – by continuing to grow their radiology portfolio. We look forward to seeing you at RSNA 2025 | Booth #3247 | South Hall

Around the web

Health Exec